Skip to main content

Table 3 Changes in the levels of inflammatory markers of patients in the group A and B

From: Changes in the levels of inflammatory markers after transthoracic device closure of ventricular septal defects in pediatric patients

item preOP POD1 POD2 POD3 POD5 POD7
WBC A 8.4 ± 1.8 16.7 ± 2.8 15.4 ± 1.9 13.2 ± 2.2 9.7 ± 4.0 8.4 ± 0.9
B 7.4 ± 2.8 15.9 ± 2.1 16.1 ± 2.6 13.6 ± 2.0 10.8 ± 1.6 8.4 ± 0.9
P 0.08 0.38 0.12 0.41 0.10 0.81
PCT A 0.36 ± 0.15 9.24 ± 3.34 8.91 ± 1.55 4.84 ± 1.22 0.77 ± 0.18 0.41 ± 0.2
B 0.32 ± 0.09 8.37 ± 1.08 9.42 ± 0.90 5.57 ± 2.06 0.81 ± 0.10 0.44 ± 0.1
P 0.14 0.1 0.07 0.06 0.23 0.37
CRP A 0.76 ± 0.7 58.6 ± 28.2 127 ± 27.8 41.9 ± 34.6 17.4 ± 9.3 4.70 ± 2.9
B 1.2 ± 1.3 68.7 ± 26.7 133 ± 25.5 57.2 ± 43.3 20.3 ± 8.5 5.40 ± 3.8
P 0.11 0.10 0.26 0.08 0.13 0.34
IL-6 A 2.9 ± 1.4 189 ± 25.8 66.8 ± 22.0 27.3 ± 26.6 10.1 ± 8.2 8.3 ± 1.6
B 3.4 ± 1.1 196 ± 21.3 72.9 ± 18.7 37.3 ± 27.4 15.1 ± 14.7 10.2 ± 6.7
P 0.10 0.17 0.18 0.10 0.07 0.10
  1. A = group A, B = group B